News & Events

  • Winners UKCGG Essay Prize 2018

    Winners UKCGG Essay Prize 2018

    posted on 16th October 2018  |  0 Comments  |  Not tagged.

    Posted from: CGG

    We had some excellent entries in the CGG Essay Prize this year, entitled "Will Artificial Intelligence Eventually Replace Cancer Geneticists"


    Huge congratulations to all our winners:




    Overall Winner and First Prize Medical Student Category  - Olivia Greatbatch

    Olivia said "I am currently in my second year of medicine at University College London, and so am in the process of deciding which intercalated BSc I wish to pursue. Given just how topical the future of artificial intelligence is across all medical specialities, it is an area which I have recently been trying to learn more about. Since both oncology and genetics are options that I am considering for intercalation, I felt that the essay competition would be a great way to gain an appreciation of what a career in these two fields may entail in the future, whilst also exploring my own interests." 

    Second Prize Medical Student Category  - Rashmi  Saincher

    Third Prize Medical Student Category  - Ayan Basu


    First Prize Junior Doctor Category  - Alice Garrett

    Second Prize Junior Doctor Category - Lara Hawkes

    Third Prize Junior Doctor Category  - George Morrissey


    First Prize Scientist Trainee Category  - Nana Mensah

     You can read their winning entries  here


     Shareable image from:

  • UKCGG Response to NICE Guideline NG85: Pancreatic Cancer

    posted on 3rd October 2018  |  0 Comments  |  Not tagged.

    Posted from: CGG

    NICE recently released their guidance on the diagnosis and management of pancreatic cancer in adults. 

    UKCGG in collaboration with other bodies, including INSIGHT, have some concerns about the recommendations for screening in familial pancreatic cancer. 

    UKCGG wish to make the following statement regarding these guidelines:



    "You may be aware that NICE published guidelines on pancreatic cancer in February 2018. These guidelines predominantly address the diagnosis and management of pancreatic cancer, but also make recommendations on screening for gene carriers and individuals at familial risk.

    Unfortunately, UKCGG was not consulted in developing these guidelines and so was not able to provide input prior to publication. We contacted NICE with our concerns when we became aware of the guideline publication specifically addressing their recommendations for screening of gene carriers (BRCA1, BRCA2, PALB2, CDKN2A, MLH1, MSH2, MSH6 and PMS2), and individuals with one or more affected relatives. We were particularly concerned that the lifetime risk of pancreatic cancer was overestimated for some genes (specifically,BRCA1, PALB2, MLH1, MSH2, MSH6 and PMS2) and secondly that the recommendations for pancreatic screening in patients who do have an increased lifetime risk are premature. NICE have replied to our concerns and the CGG Steering committee regards the response as unsatisfactory. We are planning to convene a working group with InSiGHT and the EHTG to write a review article addressing the issue further.

    We do not support the recommendations made by NICE, so, in the interim, UKCGG guidance is that pancreatic screening is only undertaken within the context of a research study e.g. EUROPAC".



     Please see the comments made by UKCGG on the guidelines here.

  • Information and outcomes from UKCGG organised consensus meetings

    posted on 7th August 2018  |  0 Comments  |  Not tagged.

    Posted from: CGG

    Information and outcomes from UKCGG organised consensus meetings can be found in the Information & Education section of this website.


Up and Coming Events